Targeting deregulated AMPK/mTORC1 pathways improves muscle function in myotonic dystrophy type I

Marielle Brockhoff, Nathalie Rion, Kathrin Chojnowska, Tatiana Wiktorowicz, Christopher Eickhorst, Beat Erne, Stephan Frank, Corrado Angelini, Denis Furling, Markus A. Rüegg, Michael Sinnreich, Perrine Castets
  • Journal of Clinical Investigation, January 2017, American Society for Clinical Investigation
  • DOI: 10.1172/jci89616

The authors haven't finished explaining this publication. If you are the author, sign in to claim or explain your work.

Read Publication

http://dx.doi.org/10.1172/jci89616

The following have contributed to this page: Prof Corrado Angelini